The latest health news
In an attempt to tackle the root causes of the inflated cost of insulin, the state of California filed a lawsuit last week accusing drug manufacturers and pharmacy benefit managers …
Read More
Two congressional committees recently released damning results of an 18-month investigation into the Food and Drug Administration’s approval of Biogen’s controversial Alzheimer’s drug, Aduhelm. The systems that enabled Biogen’s actions, …
Read More
For the third time in less than a year, a group of lawmakers is urging the Biden administration to use a controversial provision of federal law to widen access to …
Read More
The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately slows cognitive decline in people with early-stage disease. The drug, called Leqembi, was developed by …
Read More
Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug Administration and Biogen to chronicle how a controversial Alzheimer’s disease drug was approved, and how …
Read More
The high cost of prescription drugs is a very real problem in the United States. The average American spends approximately $1,300 per year on prescription drugs, more than residents of …
Read More
WASHINGTON — The Covid-19 investigations are coming. When Republicans take control of the House of Representatives in January, as the AP projected Wednesday, they’ve made it clear that probing President Biden’s …
Read More
WASHINGTON — The midterm elections this year are centered on weighty topics: the economy looms large, as does the existential future of democracy. But there are plenty of health and …
Read More
The 340B Drug Discount Program turns 30 on Nov. 4. This once-obscure drug access program began modestly, but has grown to be the second-largest federal prescription drug program, behind Medicare …
Read More